Delivery Order SPE2DB24D1205-SPE2DB24FCRHB
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $15,811.12, has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly with the Department of Defense (DoD) and...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,905.56 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This order is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The contract has a ceiling value of $7,905.56 and is a Delivery Order with a Firm Fixed Price pricing type. The award was made by the Defense Logistics Agency (DLA), a defense agency, on July 9, 2024, with a completion date of July 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The award, valued at $7,905.56, was made by the Defense Logistics Agency (DLA), a defense agency, under a Firm Fixed Price delivery order contract. The contract has an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The contract, valued at $7,905.56, was awarded by the Defense Logistics Agency (DLA) on June 18, 2024, with a completion date of July 11, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $15,811.12 for the supply of OFEV 150 MG capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this order, which has an ultimate completion date of August 6, 2024. Additionally, Amerisourcebergen holds several...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 Firm Fixed Price Delivery Order is for the supply of OFEV 150 MG CAPSULE 60S, a specialty medication. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,821.40 fixed-price delivery order contract is for the supply of OFEV 100 mg capsules. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $8,630.28, is a Delivery Order for the supply of OFEV 100 MG CAPSULE 60S. The contract has an ultimate completion date of February 26, 2025 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The contract is a Delivery Order with a Firm Fixed Price of $7,905.56 and a ceiling value of $7,905.56. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is a civilian agency within the U.S. Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCRHBDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The contract has a ceiling value of $7,905.56 and was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. government. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is June 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical products to DLA facilities supporting the DoD worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 5/15/24 |